Funding for this research was provided by:
Helse Nord RHF (HST1190-14)
Received: 6 September 2017
Accepted: 19 January 2018
First Online: 31 January 2018
: TS is trained in acupuncture and homeopathy. She holds a PhD in medical science and is specialized in both qualitative and quantitative research methodology. SAQ holds a PhD in medical anthropology and has considerable expertise in understanding the use of complementary modalities, patient-provider communication about complementary therapy use, and, in particular, survey design. JCS has a PhD in sociology, and her research interests include cancer survivorship. TAA holds a PhD in anthropology has considerable expertise in survey design and understanding of patient-provider communication. AEK is a language sociologist and a complementary therapist. She holds a PhD in medical science and is trained in quantitative research.
: The global aim of this study is to reduce risk and enhance safety for patients who combine complementary modalities and conventional treatment in cancer care and does not aim to provide new knowledge about health and disease. Therefore, regional Committees for medical and health Research Ethics (REC) decided that the study did not need REC approval (2012/1318/REK Nord). Written informed consent was obtained from all participants. The study meets the standard of the Helsinki Declaration in 1975, last revised in 2013.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.